CRSP:NASDAQ, CRISPR Therapeutics AG

CRSP stock overview

CRISPR Therapeutics AG (CRSP:NASDAQ) closed at $42.24 on November 13, 2026, down 0.89% on the day. The stock trades 33.4% below its 52-week high of $63.45 and 1.1% above its 52-week low of $41.79. Over the past year, it lost 19.6%. CRISPR Therapeutics AG is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price
$42.24
Day change
-0.89%
Volume
1,872,766
Average volume
1,624,115
Market cap
4B+
52-week range
$41.79 – $63.45
50-day average
$52.38
200-day average
$52.58

Price action over the past year

In 252 trading sessions since November 13, 2025, CRSP closed higher on 113 days (45%). Its best day was August 19, 2026 (+12.91%) and its worst was April 24, 2026 (-11.59%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CRSP news

About CRISPR Therapeutics AG

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

Similar stocks

Find more stocks like CRSP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.